Appendix

AuthorEuropean Monitoring Centre for Drugs and Drug Addiction (EU body or agency)
Pages46-50
TECHNICAL REPORT | Balancing access to opioid substitution treatment with preventing diversion of medications
46
Appendix
Table A1. Year of introduction of opioid substitution treatment medications in the European Union
Country
Methadone
High-dosage
buprenorphine
Buprenorphine
-naloxone
combination
Diacetylmorphine
(including pilots)
Slow-release
oral morphine
Austria
1987
1998
2008
NA
1998
Belgium
1994
2003
2008
2011
NA
Bulgaria
1996
NA
(2008)
NA
2006
Croatia
1991
2004
2009
NA
NA
Cyprus
NA
2007
2008
NA
NA
Czechia
1998
2000
2008
NA
NA
Denmark
1970
1999
NA
2008
NA
Estonia
2001
(2003)
NA
NA
NA
Finland
1974
1997
2004
NA
NA
France
1995
1996
2012
NA
NA
Germany
1992
2000
2007
2003
2015
Greece
1993
2002
2006
NA
NA
Hungary
1995
NA
2007
NA
NA
Ireland
1992
(2002)
(2006)
NA
NA
Italy
1975
1999
2007
NA
NA
Latvia
1996
2005
NA
NA
NA
Lithuania
1995
2002
NA
NA
NA
Luxembourg
1989
2002
NA
NA
2006
Malta
1987
2006
NA
NA
NA
Netherlands
1968
1999
NA
1998
NA
Poland
1992
2014
2008
NA
NA
Portugal
1977
1999
NA
NA
NA
Romania
1998
(2007)
2008
NA
NA
Slovakia
1997
(1999)
2008
NA
2005
Slovenia
1990
2005
2007
NA
2005
Spain
1990
(1996)
NA
2003
NA
Sweden
1967
1999
NA
NA
NA
United
Kingdom
1968
1999
2006
1920s
NA
Note: Years in brackets indicate that the treatment substance was legally available in the country but there were no
reported clients. NA stands for ‘not applicable’.
Source: EMCDDA (2019c, dataset: opioid substitution treatment — year of introduction — OST).

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT